Last updated: April 2026
Anastrozole, exemestane, and letrozole — three very different drugs that all inhibit aromatase. Understanding which to use, when, and at what dose separates good TRT management from crashing your estrogen into the floor.
Testosterone doesn't stay as testosterone. The aromatase enzyme converts a portion of T into estradiol (E2) — your brain, bones, and libido need some estrogen. But too much causes problems. The goal is balance, not elimination.
Gynecomastia (breast tissue growth), water retention/bloating, mood swings/irritability, reduced libido paradoxically (too much estrogen down-regulates receptors), headaches, high blood pressure, and testicular atrophy on-cycle.
Joint pain and stiffness, extreme fatigue, depression, cognitive fog, completely destroyed libido and ED, bone loss long-term, and hot flashes. Low E2 in men is often worse than high E2.
Target Range: Most TRT physicians target estradiol at 20–30 pg/mL (sensitive assay) for symptom-free management. Some men feel best at 30–40 pg/mL. Below 15 pg/mL = crashed estrogen. Get a sensitive estradiol assay (LC-MS/MS method) — standard immunoassays are inaccurate in men.
Different potency, different mechanism, different use cases. Know which tool to reach for.
The most commonly used AI on TRT. Competitive inhibitor — stops when you stop. Typical TRT dose: 0.25-0.5mg 2-3x/week. Oral pill. Reversible means you can easily adjust up or down. Estrogen rebounds when discontinued — important to know post-cycle.
Steroidal AI — permanently binds and destroys aromatase. No rebound when stopped (new aromatase must be synthesized, takes 4-6 days). Some users prefer this for PCT. 12.5-25mg 2-3x/week on TRT. Also has mild anabolic properties (derived from androstenedione).
Most potent AI available. Can almost completely eliminate estrogen. Rarely used on standard TRT — too easy to crash E2. Used for: gynecomastia reversal, fertility (off-label), or high-dose cycles where aromatization is extreme. Half-life ~48 hours. Use with extreme caution and bloodwork guidance.
Maximum suppression at standard therapeutic doses. Actual suppression varies by dose and individual aromatase activity.
Start low. Bloodwork should guide dose adjustments. These are starting points, not targets.
| Drug | Use Case | Dose | Frequency |
|---|---|---|---|
| Anastrozole | TRT (standard) | 0.25-0.5mg | 2x/week, with injection |
| Anastrozole | TRT (high aromatizer) | 0.5mg | 3x/week |
| Exemestane | TRT (prefer no rebound) | 12.5-25mg | 2-3x/week |
| Exemestane | On-cycle (AAS) | 25mg | EOD to daily |
| Letrozole | Gyno reversal | 1-2.5mg | Daily, short-term |
| Letrozole | High-dose cycle | 0.5-1mg | EOD — watch bloodwork |
Support your aromatase inhibitor protocol with these essentials.
Affiliate links support HighPeptides at no extra cost to you.
Third-party HPLC tested anastrozole, exemestane, and letrozole with published COAs. One of the most established research chemical vendors.
Browse Swiss Chems Compounds →Affiliate link — supports HighPeptides at no extra cost
Educational content only. Not medical advice. Aromatase inhibitors require bloodwork guidance and physician oversight. Consult a physician before starting, adjusting, or stopping any aromatase inhibitor. HighPeptides is not responsible for health outcomes.
Relevant supplies for hormone management.
Affiliate links help support HighPeptides at no extra cost to you.
This page is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare provider before starting any supplement or medication. Data sourced from published peer-reviewed research. HighPeptides may receive affiliate compensation from linked vendors.